SCHEMBL915187

SCHEMBL915187

CCOP(=O)(Cc1ccccc1C(=O)O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.45
MAPT P10636 2/20 0.43
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
TSHR P16473 3/20 0.42
CLCN2 P51788 1/20 0.42
POLB P06746 2/20 0.41
CYP2C9 P11712 1/20 0.41
HIF1A Q16665 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 3/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
NR1I2 O75469 1/20 0.41
KDM4E B2RXH2 2/20 0.40
KCNH2 Q12809 1/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
PDE3A Q14432 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8671766 0.89 MAPT (0.42) MAPTMAPK1ALDH1A1TSHRPOLB
SCHEMBL31733655 0.87 MAPT (0.51) MAPTMAPK1ALDH1A1TSHRPOLB
SCHEMBL915524 0.87 FOLH1 (0.45) FOLH1ALDH1A1TDP1TSHRCLCN2
SCHEMBL8711857 0.86 CLCN2 (0.42) FOLH1MAPTMAPK1ALDH1A1TDP1
SCHEMBL8616166 0.84 TSHR (0.59) MAPTMAPK1ALDH1A1TDP1TSHR
SCHEMBL914622 0.84 ALDH1A1 (0.51) ALDH1A1TSHRPOLBHIF1AHTT
SCHEMBL27983648 0.84 FOLH1 (0.50) FOLH1MAPTMAPK1TSHRCLCN2
SCHEMBL10696153 0.84 BCAT2 (0.56) ALDH1A1TDP1NPSR1HTTTP53
SCHEMBL9449012 0.83 HTT (0.41) MAPTMAPK1ALDH1A1TDP1TSHR
SCHEMBL28345638 0.83 MAPT (0.42) MAPTMAPK1TSHRPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250298333-A1 POLYESTER RESIN COMPOSITION, ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, DEVELOPER, AND IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2025-09-25 US disclosed
EP-2794608-B1 TETRAAZA-CYCLOPENTA[A]INDENYL AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS MERCK PATENT GMBH (DE) 2016-09-14 EP disclosed
CN-104039789-B Four azepines-cyclopenta [a] indenyl and the purposes as forward allosteric modulators thereof 默克专利股份有限公司 2016-09-07 CN disclosed
CN-101208371-B Method for preparing polyester and polyester manufactured by the method as well as polyester formed body TOYO BOSEKI 2011-08-10 CN disclosed
WO-2011075515-A1 AMINOPYRIMIDINES AS SYK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-06-23 WO disclosed
US-7868126-B2 Process for producing polyester, polyester produced using said process, and polyester molded product TOYO BOSEKI KABUSHIKI KAISHA (JP) 2011-01-11 US disclosed
EP-1842868-B1 PROCESS FOR PRODUCING POLYESTER, POLYESTER PRODUCED USING SAID PROCESS, AND POLYESTER MOLDED PRODUCT TOYO BOSEKI (JP) 2010-11-10 EP disclosed
US-20090082529-A1 Polyester, Process for Producing Polyester, and Polyester Molded Article TOYO BOSEKI KABUSHIKI KAISHA (JP) 2009-03-26 US disclosed
US-20080249280-A1 Process for Producing Polyester, Polyester Produced Using Said Process, and Polyester Molded Product TOYO BOSEKI KABUSHIKI KAISHA (JP) 2008-10-09 US disclosed
CN-101263175-A Polyester, process for production of polyester, and polyester molded article TOYO BOSEKI (JP) 2008-09-10 CN disclosed
EP-0682516-A1 THERAPEUTIC USE OF COMPOUNDS HAVING SELECTIVE AGONIST-LIKE ACTIVITY ON RXR RETINOID RECEPTORS ALLERGAN, INC. (US) 1995-11-22 EP disclosed
US-5455265-A For mammals; skin disorders, cancer, inflammatory disease, cardiovascular diorders, autoimmune diseases and others ALLERGAN, INC. (US) 1995-10-03 US disclosed
US-5399586-A Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity ALLERGAN, INC. (US) 1995-03-21 US disclosed
EP-0638581-A1 PHOSPHONIC DIESTER DERIVATIVE OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1995-02-15 EP disclosed
WO-1994020093-A1 TREATMENT OF TUMORS WITH COMPOUNDS HAVING RXR RETINOID RECEPTOR AGONIST ACTIVITY ALLERGAN, INC. (US) 1994-09-15 WO disclosed
WO-1994017796-A1 THERAPEUTIC USE OF COMPOUNDS HAVING SELECTIVE AGONIST-LIKE ACTIVITY ON RXR RETINOID RECEPTORS ALLERGAN, INC. (US) 1994-08-18 WO disclosed
US-5324840-A Skin disorders ALLERGAN, INC. (US) 1994-06-28 US disclosed
US-5242908-A Of dna and rna HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-07 US disclosed
CN-1053793-A Use the disease that benzylphosphonic acid derivatives for treatment is caused by virus HOECHST AG (DE) 1991-08-14 CN disclosed
EP-0440148-A1 Use of benzylphosphonic acid derivates for the treatment of viral diseases HOECHST AKTIENGESELLSCHAFT (DE) 1991-08-07 EP disclosed